JPM HC 2025??
Anyone have insight on how JPM HC is doing lately?? Thought it was regarded as the best group on the street but saw that Evercore just poached one of the co-heads of HC today.
Also noticed JPM has not been on majority of the major HC deals this year. Below is the list of 10bn+ HC deals announced in 2025 and looks like Centerview, GS and MS are dominating (Also no BofA???)
- JNJ / Intra-Cellular ($14.6bn) Buy-side: Citi | Sell-side: Centerview & Jefferies
- Sycamore / Walgreens ($23.7bn) Buy-side: UBS & GS & JPM & Citi & WF | Sell-side: Centerview & MS
- Merck / Verona ($10bn) Buy-side: Citi & MS | Sell-side: Centerview
- BD / Waters ($17.5bn) Buy-side: Barclays | Sell-side: Citi & Evercore
- Blackstone & TPG / Hologic ($18.3bn) Buy-side: Citi | Sell-side: GS
- Novartis / Avidity ($12bn) Buy-side: Gordon & Dyal | Sell-side: Barclays & GS
- Kimberly Clark / Kenvue ($48.7bn) Buy-side: PJT & JPM | Sell-side: Centerview & GS
- Abbott / Exact Sciences ($21bn) Buy-side: MS | Sell-side: Centerview & XMS
.
For 2025, top groups are CVP for biopharma sell-side M&A. Best large-cap buy-side banks are GS and Citi. HC services Moelis is fine.
Citi HC to the moon! JPM falloff in HC to CVP/Citi might be at the hands of that former JPM/PWP hire they made along with the GS HC senior going to Citi a few years back. CVP Tokat is the second coming of Jesus in HC.
lol
Qui delectus ut quisquam voluptatem tenetur doloremque. Quia harum quia quibusdam nemo dicta. Voluptatibus delectus qui laboriosam deserunt nostrum. Amet incidunt rerum est voluptatem minima repellendus.
Quae et omnis accusantium alias. Enim qui veniam quia quasi sint. Itaque illum deserunt numquam sed exercitationem et. Et laborum consequatur eveniet quo ducimus repellat in et. Debitis consequatur sequi ratione placeat quo nesciunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...